1. Home
  2. BIRK vs BIO Comparison

BIRK vs BIO Comparison

Compare BIRK & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Birkenstock Holding plc

BIRK

Birkenstock Holding plc

HOLD

Current Price

$45.75

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$307.43

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIRK
BIO
Founded
1774
1952
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.2B
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
BIRK
BIO
Price
$45.75
$307.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$67.45
$358.50
AVG Volume (30 Days)
1.8M
158.4K
Earning Date
12-18-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
178.47
N/A
EPS
1.92
N/A
Revenue
$2,380,334,704.00
$2,557,500,000.00
Revenue This Year
$18.19
$1.77
Revenue Next Year
$14.16
$2.30
P/E Ratio
$23.67
N/A
Revenue Growth
17.60
N/A
52 Week Low
$38.16
$211.43
52 Week High
$62.66
$373.69

Technical Indicators

Market Signals
Indicator
BIRK
BIO
Relative Strength Index (RSI) 65.19 44.28
Support Level $42.38 $307.08
Resistance Level $46.37 $319.50
Average True Range (ATR) 1.43 8.41
MACD 0.38 -1.57
Stochastic Oscillator 91.24 18.63

Price Performance

Historical Comparison
BIRK
BIO

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: